Clinical Trial Update: Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update for Prochymal adult mesenchymal stem cells in moderate-to-severe Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• PROCHYMAL (allogeneic mesenchymal stem cells)

Snippet

Sponsor: Mesoblast, Inc. | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED